FDA Center for Drug Evaluation & Research Issues Warning Letter to D&H Medical Services
June 17, 2026
June 17, 2026
WASHINGTON, June 17 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to D&H Medical Services from its Center for Drug Evaluation and Research:
* * *
Recipient: D&H Medical Services, 2500 NW 79th Avenue, Suite 265, Doral, FL 33122, United States, info@dhmedicalcenter.com
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
WARNING LETTER
* * *
Recipient: D&H Medical Services, 2500 NW 79th Avenue, Suite 265, Doral, FL 33122, United States, info@dhmedicalcenter.com
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
WARNING LETTER
